1. Home
  2. GBTG vs HAE Comparison

GBTG vs HAE Comparison

Compare GBTG & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Business Travel Group Inc.

GBTG

Global Business Travel Group Inc.

HOLD

Current Price

$5.51

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$59.67

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBTG
HAE
Founded
2014
1971
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
GBTG
HAE
Price
$5.51
$59.67
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$9.40
$85.38
AVG Volume (30 Days)
1.7M
652.4K
Earning Date
06-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
173.33
44.54
EPS
0.22
2.46
Revenue
$2,718,000,000.00
$910,373,000.00
Revenue This Year
$22.33
N/A
Revenue Next Year
$3.58
$5.46
P/E Ratio
$24.98
$24.17
Revenue Growth
12.17
N/A
52 Week Low
$4.96
$47.32
52 Week High
$8.64
$87.32

Technical Indicators

Market Signals
Indicator
GBTG
HAE
Relative Strength Index (RSI) 41.55 34.40
Support Level $4.96 $48.47
Resistance Level $5.88 $66.86
Average True Range (ATR) 0.27 1.85
MACD 0.07 0.04
Stochastic Oscillator 58.89 10.18

Price Performance

Historical Comparison
GBTG
HAE

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: